CA41892-9M1 - 0x00000000000063C4
Healthy Males & Females
Alloy
* El estipendio puede pagar hasta el monto reflejado.
Start Date:
September 24, 2024 - 3:15pm
End Date:
October 2, 2024 - 10:00am
Study Details
Study Number: CA41892
Group Number: 9M1
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,000.00
Study Criteria
Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat multiple sclerosis.
Route of Administration: Oral
Blood Draws: 20
Study Schedule
Schedule Type: Short stays with returns
Study Length: 4 Night Stay & 1 Return
Screening Dates:
| Event Day | Event Date |
|---|---|
| Monday | 9/23/2024 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Monday | 9/23/2024 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Tuesday | 9/24/2024 3:15:00 PM | Saturday | 9/28/2024 10:00:00 AM | 1 | Lincoln |
| Return | Wednesday | 10/2/2024 8:30:00 AM | Wednesday | 10/2/2024 10:00:00 AM | 1 | Lincoln |
